Related references
Note: Only part of the references are listed.Cytoprotective signaling by activated protein C requires protease-activated receptor-3 in podocytes
Thati Madhusudhan et al.
BLOOD (2012)
Human RAGE antibody protects against AGE-mediated podocyte dysfunction
Sandra Mueller-Krebs et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Everolimus and Sirolimus in Combination with Cyclosporine Have Different Effects on Renal Metabolism in the Rat
Rahul Bohra et al.
PLOS ONE (2012)
Efficacy and Safety of Early Cyclosporine Conversion to Sirolimus with Continued MMF-Four-Year Results of the Postconcept Study
Y. Lebranchu et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
The ORION Study: Comparison of Two Sirolimus-Based Regimens versus Tacrolimus and Mycophenolate Mofetil in Renal Allograft Recipients
S. M. Flechner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Conversion from sirolimus to everolimus in kidney transplant recipients receiving a calcineurin-free regimen
Catarina Carvalho et al.
CLINICAL TRANSPLANTATION (2011)
Benfotiamine Protects against Peritoneal and Kidney Damage in Peritoneal Dialysis
Lars P. Kihm et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial
Klemens Budde et al.
LANCET (2011)
Improvement in Chronic Renal Failure after Mycophenolate Mofetil Introduction and Cyclosporine Dose Reduction: Four-Year Results From a Cohort of Heart Transplant Recipients
N. Manito et al.
TRANSPLANTATION PROCEEDINGS (2011)
Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway
Melinda Oroszlan et al.
TRANSPLANT IMMUNOLOGY (2010)
Sirolimus interacts with pathways essential for podocyte integrity
Emmanuel Letavernier et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Mammalian Target of Rapamycin: Discovery of Rapamycin Reveals a Signaling Pathway Important for Normal and Cancer Cell Growth
James J. Gibbons et al.
SEMINARS IN ONCOLOGY (2009)
mTOR regulates expression of slit diaphragm proteins and cytoskeleton structure in podocytes
Beate Vollenbroeker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A
Christian Faul et al.
NATURE MEDICINE (2008)
Prospective comparison of the use of sirolimus and cyclosporine in recipients of a kidney from an expanded criteria donor
Antoine Durrbach et al.
TRANSPLANTATION (2008)
Reduced exposure to calcineurin inhibitors in renal transplantation
Henrik Ekberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes
Etsuko Yanagida-Asanuma et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression
N. Eto et al.
KIDNEY INTERNATIONAL (2007)
High sirolimus levels may induce focal segmental glomerulosclerosis de novo
Emmanuel Letavernier et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function
Katarzyna Jastrzebski et al.
GROWTH FACTORS (2007)
Everolimus inhibits glomerular endothelial cell proliferation and VEGF, but not long-term recovery in experimental thrombotic microangiopathy
Katja Keller et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling
K Asanuma et al.
NATURE CELL BIOLOGY (2006)
Resolution of sirolimus-induced pneumonitis after conversion to everolimus
B. Rehm et al.
TRANSPLANTATION PROCEEDINGS (2006)
The podocyte's response to injury: Role in proteinuria and glomerulosclerosis
S. J. Shankland
KIDNEY INTERNATIONAL (2006)
WT1-interacting protein and ZO-1 translocate into podocyte nuclei after puromycin aminonucleoside treatment
M Rico et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Synaptopodin regulates the actin-bundling activity of α-actinin in an isoform-specific manner
K Asanuma et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex
DD Sarbassov et al.
SCIENCE (2005)
Calcineurin inhibitors in heart transplantation
A Keogh
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Renal insufficiency and end-stage renal disease in the heart transplant population
JR Rubel et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Chronic renal failure after transplantation of a nonrenal organ
AO Ojo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Sirolimus therapy without calcineurin inhibitors: Necker Hospital 8-year experience
E Morelon et al.
TRANSPLANTATION PROCEEDINGS (2003)
Review of the proliferation inhibitor everolimus
B Nashan
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2002)
Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control
R Loewith et al.
MOLECULAR CELL (2002)
Interaction with podocin facilitates nephrin signaling
TB Huber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome
S Doublier et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Pharmacokinetics of SDZ RAD and cyclosporin including their metabolites in seven kidney graft patients after the first dose of SDZ RAD
GI Kirchner et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2000)
Share Paper
